|
US6127341A
(en)
*
|
1997-06-20 |
2000-10-03 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
WO1998058950A1
(en)
*
|
1997-06-20 |
1998-12-30 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
PT1077941E
(pt)
*
|
1998-05-11 |
2010-07-01 |
Novo Nordisk As |
Compostos com propriedades de libertaão da hormona de crescimento
|
|
TW450954B
(en)
*
|
1998-05-14 |
2001-08-21 |
Pharmacia & Amp Upjohn Company |
Phenylsulfonamide-phenylethylamines useful as dopamine receptors
|
|
BRPI9911756B1
(pt)
*
|
1998-06-30 |
2016-06-14 |
Helsinn Healthcare Sa |
composto, uso do mesmo, e composição farmaceutica
|
|
US6919315B1
(en)
|
1998-06-30 |
2005-07-19 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
EP1158996A4
(en)
|
1999-02-18 |
2005-01-12 |
Kaken Pharma Co Ltd |
NEW AMIDE SECRETAGOGUES OF GROWTH HORMONE DERIVATIVES
|
|
UA73530C2
(uk)
*
|
1999-11-10 |
2005-08-15 |
Ново Нордіск А/С |
Сполука з властивостями вивільнювати гормон росту
|
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
DE60124080T2
(de)
*
|
2000-03-23 |
2007-03-01 |
Elan Pharmaceuticals, Inc., San Francisco |
Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
|
|
US7087632B2
(en)
*
|
2001-03-05 |
2006-08-08 |
Transtech Pharma, Inc. |
Benzimidazole derivatives as therapeutic agents
|
|
US6613801B2
(en)
*
|
2000-05-30 |
2003-09-02 |
Transtech Pharma, Inc. |
Method for the synthesis of compounds of formula I and their uses thereof
|
|
ATE446758T1
(de)
|
2000-05-31 |
2009-11-15 |
Pfizer Prod Inc |
Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
|
|
EP1299352B1
(en)
*
|
2000-06-30 |
2005-12-28 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
EP1666452A2
(en)
|
2000-06-30 |
2006-06-07 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
|
SI1368336T1
(sl)
*
|
2001-02-16 |
2006-10-31 |
Allelix Neuroscience Inc |
S tiofenom substituirani aminski derivati kot inhibitorji glyt-1
|
|
CN1494425B
(zh)
*
|
2001-03-05 |
2011-12-07 |
特兰斯泰克制药公司 |
用作治疗剂的羧酰胺衍生物
|
|
EP1401452A1
(en)
*
|
2001-06-27 |
2004-03-31 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease
|
|
US20070213407A1
(en)
*
|
2001-06-29 |
2007-09-13 |
Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc |
Compounds to treat Alzheimer's disease
|
|
BR0306811A
(pt)
*
|
2002-01-11 |
2004-10-26 |
Sankyo Co |
Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
|
|
US7230133B2
(en)
|
2003-05-01 |
2007-06-12 |
Bristol-Myers Squibb Company |
Malonamides and malonamide derivatives as modulators of chemokine receptor activity
|
|
EP1635823A1
(en)
*
|
2003-05-20 |
2006-03-22 |
TransTech Pharma Inc. |
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
|
JP2005272453A
(ja)
|
2004-02-24 |
2005-10-06 |
Sankyo Co Ltd |
アミノアルコール化合物
|
|
KR20070010151A
(ko)
*
|
2004-03-30 |
2007-01-22 |
사파이어 세라퓨틱스, 인크. |
성장 호르몬 분비촉진제를 이용하여 ｃ-반응성 단백질을감소시키는 방법
|
|
CN1976921B
(zh)
*
|
2004-06-29 |
2013-08-21 |
蓝宝石治疗公司 |
(3r)-1-(2-甲基丙氨酰-d-色氨酰)-3-(苯甲基)-3-哌啶羧酸1,2,2-三甲基酰肼的晶形
|
|
KR101380200B1
(ko)
*
|
2004-08-12 |
2014-04-01 |
헬신 세라퓨틱스 (유.에스.) 인크. |
성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법
|
|
EP1942193A4
(en)
|
2005-08-25 |
2010-10-27 |
Ube Industries |
METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE (S OR R) -AMINOIC ACID OR AN OPTICALLY ACTIVE (S OR R) -α-AMINO-ACID ESTER
|
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
KR20090107088A
(ko)
|
2007-02-09 |
2009-10-12 |
트랜자임 파르마 인크 |
거대고리 그렐린 수용체 조절제 및 이의 사용 방법
|
|
WO2008100448A2
(en)
*
|
2007-02-13 |
2008-08-21 |
Helsinn Therapeutics (U.S.), Inc. |
Method of treating cell proliferative disorders using growth hormone secretagogues
|
|
AU2008232709C1
(en)
|
2007-03-28 |
2015-01-15 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
TWI429436B
(zh)
*
|
2007-04-10 |
2014-03-11 |
Helsinn Therapeutics Us Inc |
使用生長激素促泌素治療或預防嘔吐之方法
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
ES2467923T3
(es)
|
2009-09-30 |
2014-06-13 |
Transtech Pharma, Llc |
Derivados de imidazol substituidos para el tratamiento de la enfermedad de Alzheimer
|
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
BR112015009470A2
(pt)
|
2012-11-01 |
2019-12-17 |
Aileron Therapeutics Inc |
aminoácidos dissubstituídos e seus métodos de preparação e uso
|
|
US9119832B2
(en)
|
2014-02-05 |
2015-09-01 |
The Regents Of The University Of California |
Methods of treating mild brain injury
|
|
WO2016049359A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2017075535A1
(en)
|
2015-10-28 |
2017-05-04 |
Oxeia Biopharmaceuticals, Inc. |
Methods of treating neurodegenerative conditions
|
|
WO2017139317A1
(en)
|
2016-02-09 |
2017-08-17 |
Lumeova, Inc |
Ultra-wideband, wireless optical high speed communication devices and systems
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
JP7464591B2
(ja)
|
2018-10-10 |
2024-04-09 |
ブイティーブイ・セラピューティクス・エルエルシー |
［３－（４－｛２－ブチル－１－［４－（４－クロロ－フェノキシ）－フェニル］－１ｈ－イミダゾール－４－イル｝－フェノキシ）－プロピル］－ジエチル－アミンの代謝産物
|